InfuSystem (NYSE:INFU) Upgraded to Strong-Buy at StockNews.com

StockNews.com upgraded shares of InfuSystem (NYSE:INFU) from a buy rating to a strong-buy rating in a report issued on Friday.

InfuSystem Stock Up 1.6 %

INFU opened at $5.55 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59. The stock has a market capitalization of $118.02 million, a price-to-earnings ratio of 92.52 and a beta of 1.75. The business has a 50-day moving average of $7.65 and a two-hundred day moving average of $7.55. InfuSystem has a 12 month low of $5.28 and a 12 month high of $9.97.

Hedge Funds Weigh In On InfuSystem

Several hedge funds and other institutional investors have recently modified their holdings of the company. Two Sigma Investments LP lifted its stake in shares of InfuSystem by 40.4% in the 4th quarter. Two Sigma Investments LP now owns 36,252 shares of the company’s stock valued at $306,000 after purchasing an additional 10,427 shares in the last quarter. Nuveen Asset Management LLC lifted its stake in shares of InfuSystem by 14.1% in the 4th quarter. Nuveen Asset Management LLC now owns 86,379 shares of the company’s stock valued at $730,000 after purchasing an additional 10,647 shares in the last quarter. Meros Investment Management LP lifted its stake in shares of InfuSystem by 2.6% in the 4th quarter. Meros Investment Management LP now owns 631,105 shares of the company’s stock valued at $5,333,000 after purchasing an additional 16,178 shares in the last quarter. Millennium Management LLC lifted its stake in shares of InfuSystem by 6.3% in the 4th quarter. Millennium Management LLC now owns 76,419 shares of the company’s stock valued at $646,000 after purchasing an additional 4,532 shares in the last quarter. Finally, Deutsche Bank AG lifted its stake in shares of InfuSystem by 148.3% in the 4th quarter. Deutsche Bank AG now owns 27,671 shares of the company’s stock valued at $234,000 after purchasing an additional 16,526 shares in the last quarter. 71.13% of the stock is owned by institutional investors and hedge funds.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.